← All medicines
Nexviadyme 100 mg powder for concentrate for solution for infusion
Licence EU/1/21/1579/001-004 · Unknown
- Licence holder
- Sanofi B.V. (all products →)
- Active substance
- Avalglucosidase Alfa
- Dosage form
- Powder for concentrate for solution for infusion
- Route of administration
- Intravenous use
- ATC code
- A16AB22
- First authorised
- 24/06/2022
- Prescription status
- Product subject to prescription which may not be renewed (A)
- Supply
- Supply through pharmacies only
- Legal basis
- New active substance (Article 8(3) of Directive No 2001/83/EC)
Data: Health Products Regulatory Authority (HPRA) open dataset, licensed CC BY 4.0, published 04 Jul 2026. This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.